| zurück | EORTC-Studien: Sarkom und Knochen-Tumoren | ||
| Allgemeines | EORTC Soft Tissue and Bone Sarcoma Group | ||
| 1202 | Randomized phase II trial of cabazitaxel or prolonged infusional ifosfamide in metastatic or inoperable locally advanced dedifferentiated liposarcoma | ||
| 62092 | A phase III randomized study of preoperative radiotherapy plus surgery versus surgery alone for patients with Retroperitoneal sarcomas (RPS) - STRASS | ||
| 62091 | TRUSTS : A phase IIb/III multicenter study comparing the efficacy of Trabectedin administered as a 3-hour or 24 hour infusion to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma | ||
| 62063 | A phase III randomized study evaluating surgery of residual disease in patients with metastatic gastro-intestinal stromal tumor responding to Imatinib mesylate. | ||
| 62072 | A randomized double blind phase III trial of Pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or following prior therapy. | ||
| 62052 | Phase II study of E7389 administered as an IV infusion on day 1 and 8 every 3 weeks in pretreated patients with advanced and/or metastatic soft tissue sarcoma | ||
| 62061 | Randomized phase II study of brostallicin (PNU-166196A) versus doxorubicin as first line chemotherapy in patients with advanced or metastatic soft tissue sarcoma | ||
| 62043 | Phase II study of GW786034 in patients with relapsed or refractory soft tissue sarcoma | ||
| 62024 | Intermediate and high risk localized,completely resected, gastrointestinal stromal tumors (GIST) expressing KIT receptor : a controlled randomized trial on adjuvant Imatinib mesylate (Glivec) versus no further therapy after complete surgery. | ||
| 62027 | Phase 2 study of Glivec (Imatinib) in locally advanced and/or metastatic soft tissue sarcomas expressing the t(17;22) (q22;q13) translocation resulting in a COL1A1/PDGF- beta fusion protein i.e. DermatoFibroSarcoma Protuberans (DFSP) and Giant Cell Fibroblastoma (GCF) | ||
| 62012 | Randomised trial of single agent doxorubicin versus doxorubicin plus ifosfamide in the first line treatment of advanced or metastatic soft tissue sarcoma | ||
| 62022 | Phase 2 study of Iressa (ZD 1839) in locally advanced and/or metastatic synovial sarcoma expressing HER1/EGFRI. | ||
| 62006 | Exatecan as second line treatment in advanced adult soft tissue sarcoma: A phase II study of the EORTC Soft Tissue and Bone sarcoma Group. (Study only open for patients with Leiomyosarcoma) | ||
| 62011 | Efficacy and safety study of Brostallicin in patients with locally advanced or metastatic soft tissue sarcoma failing one prior chemotherapy treatment | ||
| 62991 | Phase II pilot study of moderate dose radiotherapy for inoperable aggressive fibromatosis | ||
| 62002 | Phase I study to determine the safety of Caelyx (Doxorubicin HCI, pegylated liposomal) in combination with Ifosfamide in previously untreated adult patients with advanced and/or metastatic soft tissues sarcomas. | ||
| 62981 | EURO-EWING 99 EUROpean Ewing tumour Working Initiative of National Groups Ewing Tumour Studies 1999 | ||
| 62005 | Phase III randomised, intergroup, international trial assessing the clinical activity of STI-571 at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumours (GIST) expressing the KIT receptor tyrosine kinase (CD117) | ||
| 62993 | A phase II study to evaluate the role of weekly Cisplatin with oral Etoposide in Ewing's sarcoma and primitive neuroectodermal tumour (PNET) with metastasis outside the lung and the pleura. | ||
| 62001 | Dose finding and phase II study of STI 571 in advanced soft tissue sarcoma. | ||
| 62982 | Phase II study on ET-743 in advanced soft tissue sarcomas of the adult. | ||
| 62972 | Phase II Study on Gemcitabine in advanced soft tissue sarcomas of the adult | ||
| 62971 | Randomized phase III trial of two investigational schedules of Ifosfamide versus standard dose Doxorubicin in patients with advanced or metastatic soft tissue sarcoma. | ||
| 62951 | Phase II study on Tomudex in advanced soft tissue sacromas of the adult | ||
| 62961 | Randomized study comparing neoadjuvant chemotherapy Etoposide + Ifosfamide + Adriamycin (EIA) combined with regional hyperthermia (RHT) Vs neoadjuvant chemotherapy alone in the treatment of high-risk soft tissue sarcomas in adults. An Intergroup study with the European Society for hyperthermic oncology. | ||
| 62962 | Phase II Study of Caelyx (Doxorubicin HCl, pegylated liposomal) or Doxorubicin in previously untreated adult patients with advanced and/or metastatic soft tissue sarcomas. | ||
| 62953 | Phase II study on HD Ifosfamide in advanced soft tissue sarcomas of the adult | ||
| 62922 | Phase II trial of temozolomide in adult patients with advanced soft tissue sarcoma | ||
| 62933 | Metastasectomy and chemotherapy for lung metastases from soft tissue sarcoma. A randomized phase III study (an Intergroup Study with the Scandinavian Sarcoma Group) | ||
| 62941 | Randomized multicenter phase III trial comparing Docetaxel to Doxorubicin in previously untreated patients with advanced and/or metastatic soft tissue sarcoma | ||
| 62931 | Randomized phase III trial of adjuvant chemotherapy with high-dose doxorubicin, ifosfamide and lenograstim in high grade soft tissue sarcoma. | ||
| 62932 | Phase II study of daily oral vepeside (etoposide VP16-213) as second line treatment in advanced soft tissue sarcomas | ||
| 80931 | EORTC/MRC/SIOP/UKCCSG/CSG collaborative phase III randomized trial of chemotherapy with or without granulocyte colony-stimulating factor in operable osteosarcoma | ||
| 62921 | A phase II trial with taxotere (RP56976) in advanced soft tissue sarcomas of the adult | ||
| 62903 | Randomized phase III study comparing conventional dose Doxorubicin plus Ifosfamide vs high dose Doxorubicin plus Ifosfamide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in the treatment of advanced soft tissue sarcomas in adults | ||
| 62912 | Randomized phase II study comparing two different Ifosfamide dose regimens | ||
| 62911 | Phase II study of liposomal muramyl tripeptide phosphatidylethanolamine (MTP/PE) in advanced soft tissue sarcoma of the adult | ||
| 62901 | Randomized phase II-III study comparing adriamycin versus two schedules of high dose Epirubicin in advanced soft tissue sarcoma | ||
| 62902 | PHASE II STUDY OF DAILY ORAL MILTEFOSINE (HEXADECYLPHOSPHOCHOLINE) IN ADVANCED SOFT TISSUE SARCOMAS OF THE ADULT. | ||
| 62883 | Phase II clinical study of the use of granulocyte-macrophage colony-stimulating factor (GM-CSF) with chemotherapy (adriamycin andifosfamide) in the treatment of advanced soft tissue sarcomas in adults | ||
| 62882 | PHASE II TRIAL OF FOTEMUSTINE IN PATIENTS WITH ADVANCED SOFT TISSUE SARCOMA | ||
| 62881 | PHASE II STUDY OF ACNU IN METASTATIC SOFT TISSUE SARCOMA | ||
| 62874 | Randomized phase II study of neoadjuvant chemotherapy in soft tissue sarcomas in adults | ||
| 62871 | Phase II Chemotherapy with m-Azidopyrimethamine in Adults with Metastatic Soft Tissue Sarcoma (Summary Last Modified 05/88) | ||
| 62863 | Phase II study of Mitozolomide in metastatic soft tissue sarcoma | ||
| 62862 | Phase II study of Iproplatin in advanced Osteogenic Sarcoma | ||
| 62861 | Phase II Chemotherapy with Methylene Dimethane Sulphonate in Patients with Soft Tissue Sarcomas | ||
| 62851 | Phase III trial of first line chemotherapy (adriamycin vs adriamycin + ifosfamide vs cyvadic) in advanced soft tissue sarcoma | ||
| 62832 | Phase II study of Ifosfamide in advanced osteosarcoma | ||
| 62771 | Randomized trial for Adjuvant Chemotherapy in soft tissue sarcoma | ||
| 1317 | Phase II study of cabozantinib in patients with gastrointestinal stromal tumor (GIST) who progressed during neoadjuvant, adjuvant or palliative therapy with imatinib and sunitinib | ||
| 62831 | Phase II clinical study of VP16-213 (etoposide) in advanced soft tissue sarcoma in adults | ||
| 62793 | Phase II study of PALA in soft tissue sarcoma | ||
| 62792 | Phase II trial of low dose methotrexate in soft tissue sarcoma | ||
| 62761 | Phase III trial comparing two schedules of cyvadic in metastatic soft tissue sarcoma | ||
| 62782 | Phase II trial of high dose versus low dose methotrexate in advanced osteosarcoma | ||
| 62794 | Phase II trial of cisplatin in advanced osteosarcoma | ||
| 62801 | Phase II-III trial of adriamycin versus 4'epiadriamycin in advanced soft tissue sarcoma | ||
| 62802 | Phase II trial of adriamycin versus carminomycin in advanced soft tissue sarcoma | ||
| 62803 | Phase II trial of 9-hydroxy-2N-methyl-ellipticinium (9HME) in advanced soft tissue sarcoma in adults | ||
| 62841 | Phase II trial of high dose DTIC in advanced soft tissue sarcomas of the adult | ||
| 62842 | Phase II clinical trial of ifosfamide + adriamycin in advanced soft tissue sarcoma in adults | ||
| 62843 | Phase II clinical study of TGU in advanced soft tissue sarcoma in adults (quick procedure) | ||
| 62812 | Phase II clinical trial of mitomycin C in advanced soft tissue sarcomas in adults | ||
| 62821 | Randomized phase II study of cyclophosphamide versus ifosfamide in advanced soft tissue sarcoma | ||
| 62873 | Phase II study of the combination doxorubicin/ifosfamide/DTIC in advanced soft tissue sarcomas of the adult | ||
| 62113 | A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in High Grade Undifferentiated Uterine Sarcoma (HGUS) after stabilization or response to doxorubicin +/- ifosfamide following surgery or in metastatic first line treatment | ||
| 55116 | A Phase III Randomized Trial of Gemcitabine plus Docetaxel followed by Doxorubicin v. observation for uterus-limited, High Grade Uterine Leiomyosarcoma | ||
| 1225 | Phase II study of anti-IGF-1R/IR (A7487/OSI-906) in patients with relapsed and/or refractory Ewing Sarcoma | ||
Impressum Zuletzt geändert am 18.10.2014 17:36